Stelis Biopharma’s flagship facility receives EIR from USFDA

The integrated capabilities at Unit 2 offer significant operational flexibility, greater efficiency, and varied scope within the same premise

US FDA inspection at Gland Pharma's Dundigal facility, Hyderabad

The company has received 1 (ONE) observation on Form 483 with respect to ANDA filed for the product to be manufactured at the said Facility.

PIB: Quality control of Ayush drugs

Wacker to expand mRNA-based actives capacity at Halle, Germany

Company is investing more than €100 million in the expansion of the Halle site

GXO Logistics opens new warehouse for pharmaceutical sector

Facility features LED lighting, solar panels, automation and innovative temperature-controlled systems to maximize efficiency and minimize environmental impact

Propanc Biopharma undertaking PRP manufacturing & development for human use

PRP is a mixture of two proenzymes, trypsinogen and chymotrypsinogen from bovine pancreas administered by intravenous injection

Sun gets 10 observations from USFDA for Halol facility

The company is preparing the response to the observations, which will be submitted to the USFDA within 15 business days

WHO suspends supply of Covaxin under Covax facility

WHO’s post EUA inspection found deficiencies in Good Manufacturing Practice at the facility

Thyssenkrupp bags order for a pharma-grade SFE plant for solids extraction

The scope of supply includes the skid-mounted plant as well as on-site installation and commissioning support

GMP certification for Exothera further extends its viral vector manufacturing capacity

The expansion makes Exothera one of the largest viral vector facilities in Europe